Phenotype-defining functions of multiple non-coding RNA pathways

Abstract

One of the surprising revelations of the initial stage of the ENCODE project was the conclusion that more than 90% of human genome is transcribed. A major component of this vast transcriptional output is represented by highly heterogeneous families of transcripts defined as short non-coding RNAs (sncRNAs) with no or limited protein-coding potentials. Here we carried out the sequence homolog profiling of the 2301 human sncRNAs with confirmed sequence identities [including 943 transintrons; 235 expressed distal intergenic sequences (EDIS); and 1005 piRNAs] as well as >1000 hypothetical transcripts derived from allelic variants of human SNP sequences with strong associations to human diseases or linkages to phenotypes established in genome-wide association studies. Unexpectedly, this analysis reveals a structural feature common for ~85% of analyzed sncRNA sequences and 488 human microRNAs. This structural feature common for multiple seemingly unrelated sncRNA pathways points to a multitude of potential functional and regulatory implications involving mechanisms of gene expression regulation, control of biogenesis, stability and bioactivity of microRNAs, sncRNA-guided macromolecular interactions, and transcriptional basis of self/non-self discrimination by immune system. Our analysis implies that hundreds thousands of nonprotein-coding transcripts are contributing to phenotype-defining regulatory and structural features of a cell. Therefore, definitions of genes as structural elements of a genome contributing to phenotypes should be expanded beyond the physical boundaries of mRNA-encoding units. We propose an information-centered model of a cell suggesting that informasomes (the RNP complexes of sncRNAs and Argonaute proteins) represent the intracellular structures which provide the increasingly complex structural framework of genomic regulatory functions in higher eukaryotes to facilitate the stochastic (random and probabilistic) rather than deterministic mode of choices in a sequence of regulatory events defining the phenotype.

Altered expression of miR‐17‐5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients

“…Hundreds of miRNA have been identified in various species, from human to viruses. Recently, alterations of miRNA biogenesis and function together with SNP variations were suggested to contribute to an increased risk of developing 16 different human diseases, including MS [10][11][12][13].…”

Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility

“…It has been hypothesized that they exist in regulatory regions of DNA that control gene expression, or alternatively, in regions of DNA that code for microRNAs or other regulatory transcripts, as recently conceptualized by Glinsky. 27,28 Ultimately, our results and these new lines of research will encourage future studies to increase our understanding of the biological basis of PC, providing an opportunity to design new therapies.…”

Emerging genomic technologies and the concept of personalized medicine: An overview of ethical, legal and social implications

“…In addition to the genetic tests evaluating the status of relevant protein-coding genes, genetic tests based on the measurements the SNP variants, microRNAs and other classes of small non-coding RNAs will become a reality in the near future. 11 Clearly, among the major ethical, legal and social issues associated with broad genetic testing of the human population, the prevention of the effects of genetic inequity on society, including severely negative effects on individual's access to employment and health and life insurance, is a top priority. Less recognized, but perhaps an equally important issue, is the necessity to protect access to the individual's genetic information, particularly in the light of ever growing demand from the human tissue and organ transplantation market.…”